PERCHING syndrome
disease diseaseOn this page
Also known as CISS3cold-induced sweating syndrome caused by mutation in KLHL7cold-induced sweating syndrome type 3CRISPONI/cold-induced sweating syndrome 3KLHL7 cold-induced sweating syndromeKLHL7-related bohring-opitz-like/cold-induced sweating-like overlap syndromePERCHING
Summary
PERCHING syndrome (MONDO:0014890) is a disease caused by KLHL7 (GenCC Definitive), with 1 cohort gene.
At a glance
- Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
- Causal gene: KLHL7 (GenCC Definitive)
- Cohort genes: 1
- ClinVar variants: 27
Clinical features
Epidemiology
Prevalence records
2 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Cases/families | 3 | Worldwide | Validated | |
| Point prevalence | <1 / 1 000 000 | Worldwide | Validated |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | PERCHING syndrome |
| Mondo ID | MONDO:0014890 |
| OMIM | 617055 |
| Orphanet | 603684 |
| DOID | DOID:0080331 |
| UMLS | C4310742 |
| MedGen | 934709 |
| GARD | 0018278 |
| Is cancer (heuristic) | no |
Also known as: CISS3 · cold-induced sweating syndrome caused by mutation in KLHL7 · cold-induced sweating syndrome type 3 · CRISPONI/cold-induced sweating syndrome 3 · Crisponi/cold-induced sweating syndrome 3 · KLHL7 cold-induced sweating syndrome · KLHL7-related bohring-opitz-like/cold-induced sweating-like overlap syndrome · PERCHING
Data availability: 27 ClinVar variants · 4 GenCC gene-disease records.
Disease family
Classification path: disease › human disease › disease by body system or component › nervous system disorder › peripheral nervous system disorder › peripheral neuropathy › sensory peripheral neuropathy › hereditary sensory and autonomic neuropathy › cold-induced sweating syndrome - hyperthermia spectrum › cold-induced sweating syndrome › PERCHING syndrome
Related subtypes (2): Cold-induced sweating syndrome 1, cold-induced sweating syndrome 2
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
ClinVar germline variants
27 retrieved; paginated sample, class counts are floors:
8 pathogenic, 8 likely pathogenic, 4 conflicting classifications of pathogenicity, 3 uncertain significance, 3 benign, 1 pathogenic/likely pathogenic
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 1030980 | NM_001031710.3(KLHL7):c.807C>A (p.Tyr269Ter) | KLHL7 | Pathogenic | criteria provided, single submitter |
| 1228383 | NM_001031710.3(KLHL7):c.1114C>T (p.Arg372Ter) | KLHL7 | Pathogenic | criteria provided, single submitter |
| 1527856 | NM_001031710.3(KLHL7):c.642G>C (p.Trp214Cys) | KLHL7 | Pathogenic | no assertion criteria provided |
| 226127 | NM_001031710.3(KLHL7):c.1261T>A (p.Cys421Ser) | KLHL7 | Pathogenic | no assertion criteria provided |
| 226129 | NM_001031710.3(KLHL7):c.1022del (p.Leu341fs) | KLHL7 | Pathogenic | no assertion criteria provided |
| 226130 | NM_001031710.3(KLHL7):c.1115G>A (p.Arg372Gln) | KLHL7 | Pathogenic | no assertion criteria provided |
| 691635 | NM_001031710.3(KLHL7):c.249del (p.Phe83fs) | KLHL7 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 804273 | NM_001031710.3(KLHL7):c.1051C>T (p.Arg351Ter) | KLHL7 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 816804 | NM_001031710.3(KLHL7):c.565C>T (p.Arg189Ter) | KLHL7 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 1228387 | NM_001031710.3(KLHL7):c.223+5G>C | KLHL7 | Likely pathogenic | criteria provided, single submitter |
| 1228389 | NM_001031710.3(KLHL7):c.815T>C (p.Leu272Pro) | KLHL7 | Likely pathogenic | criteria provided, single submitter |
| 1341505 | NM_001031710.3(KLHL7):c.944del (p.Ser315fs) | KLHL7 | Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2584468 | NM_001031710.3(KLHL7):c.569dup (p.Thr191fs) | KLHL7 | Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2584469 | NM_001031710.3(KLHL7):c.576TCT[1] (p.Leu194del) | KLHL7 | Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2920712 | NM_001031710.3(KLHL7):c.619-349A>G | KLHL7 | Likely pathogenic | criteria provided, single submitter |
| 4532064 | NM_001031710.3(KLHL7):c.776G>A (p.Cys259Tyr) | KLHL7 | Likely pathogenic | criteria provided, single submitter |
| 487514 | NM_001031710.3(KLHL7):c.618+1G>A | KLHL7 | Likely pathogenic | criteria provided, single submitter |
| 226128 | NM_001031710.3(KLHL7):c.1258C>T (p.Arg420Cys) | KLHL7 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications |
| 279824 | NM_001031710.3(KLHL7):c.976C>T (p.Arg326Ter) | KLHL7 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications |
| 430626 | NM_001031710.3(KLHL7):c.178GTT[1] (p.Val61del) | KLHL7 | Conflicting classifications of pathogenicity | no assertion criteria provided |
| 452804 | NM_001031710.3(KLHL7):c.793+5G>C | KLHL7 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications |
| 3024162 | NM_001031710.3(KLHL7):c.254T>G (p.Val85Gly) | KLHL7 | Uncertain significance | no assertion criteria provided |
| 3064762 | NM_001031710.3(KLHL7):c.317+4A>G | KLHL7 | Uncertain significance | criteria provided, single submitter |
| 3376595 | NM_001031710.3(KLHL7):c.1463G>A (p.Gly488Asp) | KLHL7 | Uncertain significance | criteria provided, single submitter |
| 359798 | NM_001031710.3(KLHL7):c.352C>T (p.Leu118=) | KLHL7 | Benign | criteria provided, multiple submitters, no conflicts |
| 802301 | NM_001031710.3(KLHL7):c.121-5814A>G | KLHL7 | Benign | criteria provided, single submitter |
| 802302 | NM_001031710.3(KLHL7):c.936+3731_936+3735del | KLHL7 | Benign | criteria provided, single submitter |
Genes & proteins
Mendelian disease overlap and somatic drivers
GenCC: 10 · Orphanet: 5 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0
GenCC gene–disease validity (cohort genes)
the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.
| Gene | Classification | Inheritance | Disease | Records |
|---|---|---|---|---|
| KLHL7 | Definitive | Autosomal recessive | PERCHING syndrome | 10 |
Orphanet rare-disease linkage (cohort genes)
| Gene | Orphanet ID | Rare disease |
|---|---|---|
| KLHL7 | Orphanet:157820 | Cold-induced sweating syndrome |
| KLHL7 | Orphanet:603684 | KLHL7-related Bohring-Opitz-like and Crisponi/Cold-induced sweating-like overlap syndrome |
| KLHL7 | Orphanet:603689 | KLHL7-related Bohring-Opitz-like syndrome |
| KLHL7 | Orphanet:603694 | KLHL7-related Crisponi/cold-induced sweating-like syndrome |
| KLHL7 | Orphanet:791 | Retinitis pigmentosa |
Cohort genes → proteins
1 cohort genes, 1 distinct canonical proteins.
Evidence partition
| Subset | Genes |
|---|---|
| multi_evidence | 1 |
Cohort genes (full)
| Symbol | HGNC | Ensembl | UniProt | Name | Evidence |
|---|---|---|---|---|---|
| KLHL7 | HGNC:15646 | ENSG00000122550 | Q8IXQ5 | Kelch-like protein 7 | gencc,clinvar |
Cohort function summary
Lead sentence per gene, UniProt-curated.
| Symbol | Protein name | Function (lead sentence) |
|---|---|---|
| KLHL7 | Kelch-like protein 7 | Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex. |
Protein-family classification
Druggable: 0 · Difficult: 0 · Unknown: 1 · Druggable fraction: 0.0
Family distribution
Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.
| Family | Genes | Fold | FDR |
|---|---|---|---|
| Other/Unknown | 1 | 1.8× | 0.558 |
Per-gene assignment
| Symbol | Family | Druggable? | EC | InterPro (top 3) |
|---|---|---|---|---|
| KLHL7 | Other/Unknown | no | BTB/POZ_dom, Kelch_1, SKP1/BTB/POZ_sf |
Expression context
Cohort genes with no expression data: 0.
1 cohort gene are a single-cell marker in ≥1 SCXA experiment.
Breadth distribution (Bgee present_calls)
| Bucket | Genes |
|---|---|
| narrow (1-5 tissues) | 0 |
| moderate (6-20) | 0 |
| broad (>20) | 1 |
| unknown | 0 |
Top tissues across cohort
| Tissue | Cohort genes |
|---|---|
| heart right ventricle | 1 |
| oocyte | 1 |
| secondary oocyte | 1 |
Per-gene tissue summary (top 30)
| Symbol | Bgee breadth | FANTOM5 breadth | SCXA | Top tissues |
|---|---|---|---|---|
| KLHL7 | 274 | ubiquitous | marker | oocyte, secondary oocyte, heart right ventricle |
Protein interactions among cohort
Intra-cohort edges: 0.
Hub genes (top 10 by interactor count)
| Symbol | Interactor count |
|---|---|
| KLHL7 | 1,123 |
Structural data
PDB: 1 · AlphaFold-only: 0 · No structure: 0
Cohort genes with PDB structures (top 30)
| Symbol | UniProt | PDB entries |
|---|---|---|
| KLHL7 | Q8IXQ5 | 1 |
Function
Pathway analysis
Distinct Reactome pathways touched by cohort: 0. Enrichment computed across 1 evidence-associated genes (0 with Reactome annotation).
GO biological processes by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| GO term | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| proteasome-mediated ubiquitin-dependent protein catabolic process | 1 | 52.2× | 0.024 | KLHL7 |
| protein ubiquitination | 1 | 41.4× | 0.024 | KLHL7 |
Therapeutics
Drug target analysis
Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 1
Druggability breadth: 1 of 1 evidence-associated genes (100%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).
Top cohort targets by molecule count
| Symbol | Molecules | Max phase |
|---|---|---|
| KLHL7 | 0 | 0 |
Bioactivity and enzyme data
Enzyme cohort genes (≥1 EC): 0.
Cohort genes with ChEMBL bioactivity (full, sorted by assay count)
| Symbol | Assays | Type breakdown |
|---|---|---|
| KLHL7 | 1 | Binding:1 |
Pharmacogenomics
Cohort genes with a PharmGKB record: 1; with CPIC/DPWG dosing guidelines: 0.
No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).
Chemical tractability of cohort targets
0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.
Druggability pyramid
Cohort genes binned by druggability tier (high → low):
| Tier | Definition | Genes | Symbols |
|---|---|---|---|
| A | Approved (phase 4 drug) | 0 | |
| B | Phased (≥1) drug, not yet approved | 0 | |
| C | Druggable family + PDB, no drug | 0 | |
| D | Druggable family + AlphaFold only, no drug | 0 | |
| E | Difficult family or no structure, no drug | 1 | KLHL7 |
Undrugged target profiles
1 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).
| Symbol | ChEMBL assays | Drugged partners (top 3) |
|---|---|---|
| KLHL7 | 1 | — |
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
- Cohort genes: KLHL7